ArticleJournal of hematology & oncology2025

The gynecologic tumor risk related to GLP-1 receptor agonists and SGLT2 inhibitors use: a network meta-analysis of 91 randomized controlled trials.

Ping-Tao Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.